Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Pfizer Inc. | PFE | 252.4K | $6.08M |
Nektar Therapeutics | NKTR | 244.18K | $17.05M |
Xencor, Inc. | XNCR | 232.56K | $3.74M |
Insmed Incorporated | INSM | 228.52K | $24.36M |
Delcath Systems, Inc. | DCTH | 224.38K | $2.83M |
Monte Rosa Therapeutics, Inc. | GLUE | 216.75K | $5.25M |
Summit Therapeutics Inc. | SMMT | 191.87K | $2.8M |
Establishment Labs Holdings Inc. | ESTA | 185.62K | $15.93M |
BridgeBio Pharma, Inc. | BBIO | 176.69K | $13.16M |
Xenon Pharmaceuticals Inc. | XENE | 166.55K | $10.05M |
Ionis Pharmaceuticals, Inc. | IONS | 166.29K | $13.18M |
Wave Life Sciences Ltd. | WVE | 160K | $929.6K |
Avalyn Pharma Inc. Common Stock | AVLN | 146.45K | $4.82M |
Vaxcyte, Inc. | PCVX | 146.03K | $8.49M |
Edgewise Therapeutics, Inc. | EWTX | 143.2K | $5.82M |
Rhythm Pharmaceuticals, Inc. | RYTM | 136.16K | $15.12M |
BioCryst Pharmaceuticals, Inc. | BCRX | 133K | $1.33M |
Aura Biosciences, Inc. | AURA | 130.15K | $924.08K |
Avantor, Inc. | AVTR | 130K | $1.29M |
CG Oncology Inc. | CGON | 118.66K | $8.43M |